uvea
compos
highli
vascular
often
pigment
iri
ciliari
bodi
choroid
iri
ciliari
bodi
compris
anterior
uvea
choroid
compris
posterior
uvea
uveal
tract
regul
quantiti
light
allow
eye
vari
pupillari
apertur
produc
aqueou
humor
provid
nourish
remov
wast
cornea
len
provid
nutrient
outer
layer
retina
uveiti
simpli
inflamm
within
uveal
tract
precis
terminolog
describ
portion
uveal
tract
involv
includ
iriti
inflamm
iri
iridocycl
anterior
uveiti
inflamm
iri
ciliari
bodi
choroid
posterior
uveiti
inflamm
choroid
panuv
inflamm
entir
uveal
tract
differenti
whether
inflamm
aris
iri
ciliari
bodi
difficult
close
anatom
proxim
similar
clinic
sign
posterior
uveiti
occur
independ
anterior
uveiti
endophthalm
occur
ocular
inflamm
confin
three
tissu
insid
eye
panophthalm
indic
ocular
inflamm
involv
layer
eye
includ
sclera
determin
extent
involv
clinic
import
involv
posterior
segment
may
decreas
likelihood
maintain
visual
globe
therapeut
agent
must
also
administ
system
achiev
effect
within
posterior
segment
uveiti
signific
caus
ocular
diseas
dog
cat
uveiti
occur
damag
uveal
tissu
vasculatur
disrupt
ocular
bloodaqu
barrier
bab
bloodretin
barrier
bab
compos
epitheli
barrier
level
nonpig
ciliari
epithelium
endotheli
barrier
level
irid
blood
vessel
bloodretin
barrier
creat
tight
junction
within
retin
capillari
bab
prevent
movement
molecul
across
vascular
endotheli
surfac
result
aqueou
humor
protein
concentr
time
less
plasma
disrupt
bab
caus
aqueou
humor
protein
concentr
increas
greater
normal
level
result
light
scatter
tyndal
effect
make
beam
slitlamp
visibl
travers
anterior
chamber
phenomenon
known
flare
hallmark
uveiti
disrupt
bloodretin
barrier
result
retin
edema
retin
hemorrhag
detach
neurosensori
retina
acut
inflammatori
phase
uveiti
begin
brief
arteriolar
vasoconstrict
follow
prolong
vascular
dilat
prostaglandin
leukotrien
mediat
vasodil
caus
increas
vascular
permeabl
result
breakdown
bab
episod
anterior
uveiti
intraocular
prostaglandin
concentr
may
increas
prostaglandin
also
induc
hyperemia
reduct
intraocular
pressur
iop
pgf
constrict
iri
sphincter
muscl
caus
miosi
pain
recent
report
studi
measur
inflammatori
mediat
aqueou
humor
anterior
chamber
paracentesi
increas
pge
level
note
along
elev
induc
cyclooxygenas
cox
nitrit
nitrat
breakdown
bab
allow
protein
cell
addit
inflammatori
mediat
entri
irid
stroma
aqueou
humor
cytokin
chemokin
import
chemotact
factor
recruit
inflammatori
cell
one
particularli
import
cytokin
seem
leukotrien
classic
chemoattract
trigger
adher
leukocyt
endothelium
recruit
granulocyt
macrophag
site
inflamm
experiment
model
uveiti
mice
blockad
leukotrien
receptor
greatli
reduc
intens
ongo
diseas
blepharospasm
photophobia
excess
lacrim
enophthalmo
nonspecif
sign
ocular
discomfort
note
uveiti
also
ulcer
kerat
scleriti
glaucoma
globe
often
appear
red
hyperemia
deep
perilimb
anterior
ciliari
vessel
engorg
radial
orient
vessel
call
ciliari
flush
vascular
dilat
occur
secondari
elev
prostaglandin
level
deep
vessel
may
distinguish
superfici
conjunctiv
vessel
manipul
conjunctiva
applic
epinephrin
phenylephrin
solut
deep
vessel
move
conjunctiva
readili
blanch
applic
topic
epinephrin
uveiti
may
result
corneal
edema
corneal
edema
may
occur
associ
uveiti
result
reduct
endotheli
sodium
potassium
nak
atpas
epitheli
nachlorin
cl
pump
activ
may
relat
ruptur
endotheli
cellcel
junction
barrier
either
mechan
allow
hydrat
corneal
stroma
note
clinic
corneal
edema
presenc
aqueou
flare
confirm
diagnosi
anterior
uveiti
aqueou
flare
denot
breakdown
bab
increas
permeabl
ocular
vasculatur
increas
vascular
permeabl
inflammatori
cell
may
visual
within
aqueou
humor
vitreou
bodi
accumul
purul
materi
within
anterior
chamber
term
hypopyon
fig
blood
within
anterior
chamber
term
hyphema
fig
may
note
episod
anterior
uveiti
aggreg
inflammatori
cell
may
adher
corneal
endothelium
call
kerat
precipit
fig
typic
kerat
precipit
visual
ventral
one
half
one
third
cornea
deposit
aqueou
humor
thermal
convent
current
blepharospasm
elev
third
eyelid
may
prevent
visual
kerat
precipit
obscur
ventral
portion
cornea
larger
fattylook
cluster
kerat
precipit
term
mutton
fat
kerat
precipit
fig
often
indic
granulomat
inflamm
miosi
sometim
quit
mark
occur
respons
prostaglandin
particularli
pgf
inflammatori
mediat
act
directli
iri
sphincter
muscl
miosi
associ
ciliari
muscl
spasm
contribut
greatli
pain
associ
anterior
uveiti
failur
dilat
complet
respons
topic
applic
tropicamid
ophthalm
solut
subtl
sign
anterior
uveiti
irid
swell
may
caus
iri
appear
engorg
darker
color
possibl
even
yellow
anim
normal
blue
irid
iop
typic
decreas
uveiti
inflammatori
process
lead
reduct
activ
secret
aqueou
humor
possibl
mean
interfer
activ
transport
mechan
prostaglandin
releas
may
also
contribut
ocular
hypotoni
increas
aqueou
humor
outflow
uveoscler
rout
subtl
ocular
hypotoni
exampl
iop
within
normal
rang
mm
hg
less
fellow
eye
signific
find
may
earli
indic
inflamm
examin
posterior
segment
may
reveal
cellular
infiltr
within
vitreou
bodi
inflammatori
cell
diffus
vitreou
par
plana
par
plicata
ciliari
bodi
complet
fundic
examin
necessari
evalu
alter
within
retina
choroid
close
anatom
proxim
retina
choroid
choroid
infrequ
inflam
sole
process
retina
typic
involv
primarili
secondarili
area
grayish
discolor
tapet
fundu
grayish
white
area
within
nontapet
fundu
may
occur
result
retin
edema
cellular
infiltr
extens
inflamm
may
result
area
retin
detach
fig
detach
may
bullou
fluid
exud
subretin
space
allow
visual
underli
tapetum
fig
retin
detach
may
also
character
cellular
infiltr
subretin
space
appear
grayish
pinkwhit
accumul
materi
beneath
retin
detach
hemorrhag
may
present
within
vitreou
retina
subretin
space
close
inspect
retin
vasculatur
may
reveal
chang
vascular
calib
tortuos
sheath
retin
vessel
inflammatori
cell
call
perivascular
cuf
occur
form
uveiti
chronic
inflamm
previou
bout
inflamm
may
incit
multipl
chang
within
globe
chronic
inflamm
stimul
ingrowth
peripher
corneal
vascular
vessel
bud
limbal
vasculatur
matrix
metalloproteinas
within
anterior
chamber
may
one
stimuli
incit
corneal
angiogenesi
combin
inflammatori
cell
fibrin
fibroblast
irid
swell
miosi
may
creat
adhes
iri
len
capsul
cornea
posterior
synechia
occur
iri
adher
anterior
len
capsul
anterior
synechia
occur
iri
adher
corneal
endothelium
extens
posterior
synechia
may
occlud
flow
aqueou
posterior
chamber
pupil
anterior
chamber
caus
iri
anterior
balloon
iri
secondari
glaucoma
preirid
fibrovascular
membran
may
form
anterior
surfac
iri
angiogen
factor
releas
ischem
retina
neoplasm
leukocyt
involv
ocular
inflamm
incit
endotheli
bud
vessel
anterior
irid
stroma
membran
may
extend
onto
anterior
len
capsul
iridocorn
angl
clinic
term
rubeosi
iridi
appli
neovascular
membran
anterior
irid
surfac
caus
reddish
cast
iri
fig
chronic
inflamm
often
induc
format
cataract
presum
diffus
inflammatori
mediat
across
len
capsul
caus
len
epitheli
metaplasia
necrosi
posterior
migrat
len
fiber
degener
liquefact
necrosi
chronic
uveiti
may
also
result
len
luxat
inflammatori
product
within
aqueou
humor
caus
degrad
zonular
fiber
allow
len
move
normal
posit
within
patellar
fossa
although
process
seem
rel
rare
dog
chronic
uveiti
seem
frequent
caus
len
luxat
cat
secondari
glaucoma
may
occur
pupillari
block
result
iri
len
luxat
may
attribut
occlus
iridocorn
angl
peripher
anterior
synechia
resolut
chorioretin
may
leav
area
retin
degener
demarc
area
tapet
hyperreflect
tapet
fundu
overli
retina
thin
mottl
pigment
nontapet
fundu
hypertrophi
retin
pigment
epithelium
may
note
area
dens
pigment
area
previou
retin
detach
mark
choroid
inflamm
present
may
chang
tapet
color
pigment
clump
loss
choroid
pigment
expos
choroid
vessel
sclera
retin
vascular
attenu
may
gener
occur
overli
area
retin
degener
final
phthisi
bulbi
may
occur
chronic
cycliti
result
tissu
atrophi
fibrosi
destroy
abil
ciliari
bodi
produc
aqueou
humor
normal
iop
longer
maintain
globe
begin
shrink
histolog
hallmark
atroph
disorgan
globe
typic
character
cyclit
membran
variabl
degre
chronic
inflamm
fibrou
osseou
metaplasia
may
occur
well
fluorescein
stain
perform
routin
rule
presenc
ulcer
kerat
possibl
reflex
uveiti
presenc
ulcer
kerat
preclud
use
topic
corticosteroid
mani
signific
system
diseas
induc
uveiti
thorough
physic
examin
complet
blood
cell
count
serum
biochemistri
profil
urinalysi
perform
physic
examin
particular
attent
paid
integu
lymphat
system
thorac
auscult
abdomin
palpat
thorac
radiograph
abdomin
ultrasonograph
examin
select
serolog
titer
often
valuabl
tool
diagnost
investig
mark
cellular
infiltr
present
cytolog
evalu
aqueou
humor
may
benefici
identifi
etiolog
agent
neoplast
cell
particularli
case
lymphoma
risk
aqueou
centesi
low
hand
experienc
ophthalmologist
includ
cataract
format
one
contact
anterior
len
capsul
hyphema
exacerb
uveiti
mark
vitreal
infiltr
cellular
retin
detach
present
cytolog
examin
infiltr
often
reward
report
brightman
colleagu
etiolog
agent
identifi
case
use
vitreou
centesi
cytolog
examin
aqueocentesi
also
use
determin
level
intraocular
antibodi
product
ratio
aqueou
antibodi
titer
serum
titer
known
goldmanwitm
coeffici
c
valu
greater
show
intraocular
infecti
agent
caus
irid
plasma
cell
produc
antibodi
thu
demonstr
infecti
agent
caus
uveiti
rather
mere
bystand
primari
treatment
goal
uveiti
halt
inflamm
stabil
bab
minim
sequela
decreas
pain
preserv
vision
agent
use
attain
goal
includ
topic
mydriat
topic
select
case
system
corticosteroid
nonsteroid
antiinflammatori
drug
nsaid
underli
etiolog
detect
therapi
direct
toward
remov
incit
agent
allevi
associ
system
diseas
mydriat
agent
often
select
atropin
ointment
solut
atropin
select
revers
directact
anticholinerg
agent
topic
administr
result
pharmacolog
blockag
sphincter
muscl
iri
ciliari
bodi
lead
pupillari
dilat
cycloplegia
result
pupillari
dilat
decreas
possibl
posterior
synechia
format
pupillari
dilat
may
exacerb
congest
iridocorn
angl
howev
therebi
decreas
aqueou
outflow
therefor
atropin
must
use
caution
patient
risk
secondari
glaucoma
cycloplegia
greatli
lessen
pain
associ
ciliari
spasm
administr
atropin
also
decreas
permeabl
ocular
blood
vessel
protein
intraven
administ
fluorescein
therebi
stabil
bab
normal
canin
felin
globe
onset
action
within
minut
mydriasi
may
persist
day
administr
last
dose
uveit
globe
atropin
initi
appli
four
time
daili
achiev
mydriasi
administ
twice
daili
maintain
mydriasi
agent
bitter
tast
hypersaliv
infrequ
vomit
may
note
instil
topic
solut
travel
lacrim
puncta
nasolacrim
duct
tast
cat
may
particularli
mark
reaction
therefor
use
ointment
prepar
indic
felin
potenti
sensit
patient
antiinflammatori
therapi
key
element
therapi
uveiti
corticosteroid
frequent
use
suppress
inflamm
reduc
product
metabolit
arachidon
acid
inflammatori
cascad
glucocorticoid
upregul
lipocortin
express
lipocortin
key
inhibitor
proinflammatori
substanc
phospholipas
enzym
respons
initi
arachidon
acid
cascad
glucocorticoid
also
directli
reduc
pge
synthesi
increas
vascular
stabil
control
anterior
uveiti
topic
applic
corticosteroid
often
prefer
rout
allow
high
local
drug
concentr
minim
system
side
effect
prednisolon
acet
ophthalm
suspens
dexamethason
abl
penetr
intact
corneal
epithelium
therefor
topic
corticosteroid
achiev
therapeut
concentr
aqueou
humor
agent
may
inhibit
protein
exud
iri
ciliari
bodi
initi
frequenc
applic
may
everi
hour
depend
sever
inflamm
clinic
improv
note
frequenc
may
decreas
therapi
gradual
taper
diminish
likelihood
recurr
topic
corticosteroid
contraind
presenc
corneal
ulcer
delay
normal
wound
heal
use
glucocorticoid
prednison
prednisolon
dexamethason
suppress
inflamm
within
posterior
segment
exampl
chorioretin
requir
system
administr
antiinflammatori
occasion
immunosuppress
dose
dose
increment
decreas
base
respons
therapi
use
corticosteroid
one
risk
exacerb
clinic
sign
infecti
caus
present
yet
identifi
system
side
effect
includ
endocrinopathi
may
result
longterm
use
nsaid
particularli
use
case
mild
anterior
uveiti
adjunct
therapi
combin
topic
corticosteroid
control
posterior
segment
inflamm
infecti
etiolog
complet
rule
nsaid
block
convers
arachidon
acid
prostaglandin
cox
prostaglandin
key
mediat
ocular
inflamm
caus
breakdown
bab
exacerb
photophobia
lower
ocular
pain
threshold
nsaid
also
benefici
shown
suppress
polymorphonuclear
cell
locomot
chemotaxi
decreas
express
inflammatori
cytokin
function
free
radic
scaveng
although
mani
system
nsaid
current
avail
evalu
assess
efficaci
control
ocular
inflamm
flunixin
meglumin
aspirin
shown
stabil
bab
experiment
model
uveiti
flunixin
meglumin
good
effect
wherea
effect
aspirin
moder
compar
placebo
drug
induc
gastrointestin
bleed
howev
pilocarpineinduc
model
uveiti
dog
carprofen
result
inhibit
aqueou
flare
clinic
studi
tolfenam
acid
shown
control
postop
intraocular
inflamm
select
system
nsaid
one
must
cogniz
potenti
system
side
effect
particularli
advers
gastrointestin
effect
speci
potenti
bone
marrow
suppress
hemorrhag
cat
topic
nsaid
may
use
control
mild
inflamm
may
combin
topic
corticosteroid
improv
control
sever
ocular
inflamm
applic
frequenc
typic
vari
two
four
time
per
day
rel
efficaci
studi
anterior
chamber
paracentesi
model
order
bab
stabil
efficaci
follow
diclofenac
greater
flurbiprofen
flurbiprofen
greater
suprofen
suprofen
greater
tolmetin
equal
control
solut
one
must
use
caution
canin
eye
potenti
secondari
glaucoma
topic
nsaid
found
elev
iop
one
must
also
exercis
caution
use
topic
nsaid
presenc
corneal
ulcer
peopl
topic
nsaid
associ
mark
corneal
collagenolysi
case
immunemedi
uveiti
requir
longterm
mainten
system
glucocorticoid
fail
respond
convent
therapi
may
requir
use
immunosuppress
drug
azathioprin
azathioprin
purin
analogu
rel
select
cytotox
helper
lymphocyt
condit
like
uveodermatolog
syndrom
pigmentari
uveiti
condit
azathioprin
frequent
use
initi
dose
dog
mgkg
everi
hour
dose
longterm
therapi
typic
decreas
mgkg
everi
day
lag
period
success
treatment
recogn
rang
week
complet
blood
cell
count
monitor
bone
marrow
suppress
concern
gastrointestin
side
effect
hepatotox
may
note
well
plethora
etiolog
may
incit
uveiti
infecti
diseas
neoplasia
immunemedi
condit
may
present
clinic
sign
uveiti
purpos
discuss
etiolog
group
noninfecti
infecti
caus
uveiti
unfortun
case
uveiti
remain
idiopath
despit
intens
system
evalu
studi
massa
colleagu
case
dog
uveiti
classifi
idiopath
immun
mediat
underli
system
caus
could
identifi
dog
idiopath
uveiti
typic
middl
age
exhibit
sign
system
ill
often
present
unilater
uveiti
studi
massa
colleagu
degre
inflamm
ocular
lesion
vari
dog
infecti
neoplast
idiopath
uveiti
studi
felin
uveiti
approxim
affect
cat
identifi
concurr
system
diseas
although
underli
etiolog
may
often
remain
obscur
complet
diagnost
investig
remain
essenti
sever
system
diseas
associ
uveiti
excel
review
articl
topic
written
van
der
woerdt
reader
refer
text
addit
inform
two
differ
form
uveiti
may
initi
lenticular
patholog
find
lymphoplasmacyt
inflammatori
process
term
phacolyt
uveiti
occur
associ
hypermatur
rapidli
form
cataract
phacolyt
uveiti
typic
mild
preval
report
high
dog
screen
cataract
surgeri
high
preval
surpris
fluorophotometr
studi
demonstr
breakdown
bab
associ
stage
cataract
lensassoci
inflamm
propos
occur
deviat
normal
low
level
tcellmedi
toler
len
protein
dramat
form
uveiti
term
phacoclast
uveiti
occur
associ
ruptur
len
capsul
releas
len
protein
membraneassoci
antigen
histolog
examin
affect
globe
reveal
intralenticular
neutrophil
surround
inflammatori
respons
rang
suppur
lymphocyt
natur
studi
davidson
colleagu
prompt
surgic
remov
len
materi
result
visual
eye
case
contrast
attempt
medic
manag
result
loss
vision
cat
risk
traumat
ocular
sarcoma
surgic
remov
len
materi
globe
recommend
eye
salvag
ruptur
len
capsul
believ
induc
traumat
ocular
sarcoma
although
time
trauma
detect
tumor
averag
year
blunt
trauma
penetr
trauma
incit
uveiti
common
caus
uveiti
domest
anim
hyphema
vari
amount
fibrin
often
present
case
traumat
uveiti
case
penetr
trauma
one
must
assess
extent
damag
within
globe
includ
whether
len
capsul
ruptur
ultrasonograph
examin
may
requir
evalu
extent
damag
fulli
administr
broadspectrum
system
antibiot
strongli
suggest
bacteri
fungal
contamin
may
occur
time
globe
penetr
endophthalm
progress
rapidli
caus
loss
globe
mark
hyphema
present
administr
tropicamid
mobil
pupil
assist
prevent
develop
synechia
administr
tropicamid
prefer
atropin
tropicamid
produc
greater
iridoplegia
cycloplegia
thu
less
often
produc
increas
iop
primarili
report
golden
retriev
pigmentari
uveiti
character
anterior
segment
inflamm
deposit
pigment
anterior
len
capsul
often
radial
fashion
system
sign
associ
condit
mean
age
present
year
report
sapienza
colleagu
common
sequela
cataract
format
secondari
glaucoma
report
deehr
dubielzig
uveal
cyst
note
eye
thought
import
factor
develop
glaucoma
report
sapienza
colleagu
uveal
cyst
common
find
histolog
examin
enucl
glaucomat
blind
eye
wherea
note
clinic
case
interestingli
globe
microscop
littl
inflamm
note
therapi
often
consist
combin
topic
system
corticosteroid
topic
nsaid
medic
control
secondari
glaucoma
azathioprin
administr
topic
nsaid
seem
exacerb
ocular
hypertens
frequent
uveodermatolog
syndrom
vogtkoyanagiharadalik
syndrom
autoimmun
condit
dog
melanocyt
becom
target
cellular
respons
immunohistochem
examin
affect
tissu
two
dog
reveal
skin
lesion
mediat
cell
macrophag
helper
th
immun
wherea
ocular
lesion
consist
bcell
macrophag
respons
immun
breed
primarili
affect
akita
samoy
siberian
huski
shetland
sheepdog
condit
occur
sporad
breed
howev
affect
patient
usual
present
anterior
uveiti
panuv
character
irid
choroid
depigment
bullou
retin
detach
blind
ocular
lesion
may
preced
cutan
lesion
includ
poliosi
vitiligo
facial
mucocutan
junction
nasal
planum
scrotum
footpad
gener
vitiligo
may
also
occur
chronic
natur
diseas
affect
patient
typic
develop
extens
posterior
synechia
iri
cataract
secondari
glaucoma
immunosuppress
drug
mainstay
therapi
azathioprin
often
combin
substitut
corticosteroid
avoid
side
effect
associ
chronic
system
corticosteroid
administr
presenc
neoplast
process
whether
primari
metastat
within
globe
may
induc
clinic
sign
uveiti
iri
hyperpigment
intraocular
fibrin
exud
hemorrhag
therefor
possibl
associ
neoplasia
must
alway
consid
patient
uveiti
particularli
inflammatori
respons
secondari
glaucoma
preclud
complet
visual
intraocular
compart
common
primari
intraocular
tumor
includ
melanoma
dog
cat
iridociliari
epitheli
tumor
dog
lymphosarcoma
frequent
metastat
intraocular
tumor
cat
dog
ocular
involv
canin
lymphoma
may
includ
anterior
uveiti
posterior
uveiti
panuv
retin
hemorrhag
superfici
diseas
metastasi
angioinvas
pulmonari
carcinoma
describ
four
cat
ophthalm
examin
reveal
wedgeshap
tan
discolor
tapet
fundu
variabl
mild
serou
exud
retina
profoundli
attenu
retin
vasculatur
common
infecti
caus
uveiti
cat
felin
infecti
periton
fip
felin
leukemia
viru
felv
felin
immunodefici
viru
fiv
toxoplasmosi
system
mycos
bartonella
hensela
also
propos
frequent
caus
felin
uveiti
accord
previous
publish
report
cat
uveiti
associ
system
diseas
felin
infecti
periton
fip
caus
immun
respons
felin
coronaviru
induc
granulomat
necrot
phlebiti
periphleb
proteinrich
effus
bodi
caviti
granulomat
inflammatori
lesion
multipl
organ
associ
clinic
sign
includ
febril
episod
weight
loss
anorexia
depress
debil
variabl
thorac
abdomin
involv
uveiti
associ
fip
typic
panuv
panophthalm
diffus
sever
corneal
edema
mark
anterior
uveiti
mark
cellular
infiltr
vitreou
ie
vitriti
chorioretin
inflammatori
retin
detach
optic
neuriti
mutton
fat
kerat
precipit
occasion
admix
hemorrhag
occur
often
fip
granulomat
natur
infect
granulomat
periphleb
may
note
perivascular
cuf
surround
retin
vasculatur
diagnosi
fip
challeng
enter
coronavirus
crossreact
caus
posit
result
serolog
test
revers
transcriptas
rt
polymeras
chain
reaction
pcr
assay
accord
recommend
fip
workshop
symposium
first
step
establish
diagnosi
fip
compar
signal
histori
clinic
find
typic
individu
infect
fip
cat
fip
month
year
age
come
shelter
catteri
show
sign
cyclic
antibioticresist
fever
specif
physic
manifest
depend
form
diseas
locat
lesion
diagnost
test
find
support
diagnosi
fip
includ
characterist
analysi
periton
pleural
effus
leukocytosi
neutrophilia
lymphopenia
hyperglobulinemia
hypoalbuminemia
increas
fibrinogen
nonregen
anemia
chronic
diseas
final
cat
suspect
fip
one
may
also
submit
effus
surgic
biopsi
immunohistochemistri
rtpcr
serolog
rtpcr
perform
serum
sampl
confirm
exposur
felin
coronaviru
must
pair
appropri
clinic
sign
ensur
accur
diagnosi
therapi
prove
effect
manag
fip
therapi
remain
symptomat
bartonella
spp
b
hensela
first
suggest
caus
felin
anterior
uveiti
lappin
black
felin
patient
c
valu
igg
antibodi
bartonella
spp
indic
antibodi
product
ocular
tissu
clinic
respons
therapi
note
doxycyclin
administ
sinc
initi
report
ketr
colleagu
demonstr
elev
serum
antibodi
product
bartonella
cat
uveiti
recent
studi
fontanel
colleagu
howev
healthi
cat
like
elev
bartonella
titer
cat
uveiti
therefor
serum
antibodi
test
alon
seem
suffici
confirm
diagnosi
bartonellainduc
uveiti
definit
therapeut
protocol
resolv
bartonella
infect
current
exist
author
one
articl
suggest
azithromycin
doxycyclin
rifampin
ill
felvinfect
cat
result
direct
effect
viru
bone
marrow
lymphoid
tissu
uveiti
associ
felv
infect
primarili
manifest
lymphosarcoma
studi
peiffer
wilcock
felvassoci
lymphosarcoma
third
frequent
caus
uveiti
cat
idiopath
lymphoplasmacyt
uveiti
fipassoci
uveiti
felvinduc
lesion
rang
inflammatori
cell
fibrin
within
anterior
chamber
small
iri
nodul
extens
neoplast
infiltr
funduscop
one
may
note
characterist
lesion
retinopathi
anemia
may
occur
secondari
felvrel
anemia
cytolog
examin
aqueou
humor
usual
reveal
variabl
amount
lymphocyt
occasion
plasmacyt
neutrophil
presenc
lymphosarcoma
may
confirm
base
bone
marrow
aspir
lymph
node
biopsi
direct
biopsi
intraocular
mass
elisa
antigen
test
peripher
blood
demonstr
presenc
felv
antigen
diagnosi
persist
infect
confirm
perform
immunofluoresc
antibodi
ifa
test
repeat
elisa
antigen
test
month
direct
viral
damag
ocular
tissu
initi
secondari
immun
phenomena
opportunist
infect
secondari
immunosuppress
may
contribut
uveiti
associ
fiv
infect
clinic
par
planiti
often
signific
featur
diseas
creat
snow
bank
phenomenon
cell
deposit
throughout
anterior
vitreou
greater
densiti
toward
peripheri
kerat
precipit
uncommon
find
coinfect
toxoplasma
gondii
seem
increas
sever
clinic
sign
cat
infect
fiv
perhap
defens
mechan
gondii
depend
cell
elisa
test
may
use
detect
antibodi
fiv
accord
recent
studi
snap
combo
plu
idexx
laboratori
atlanta
ga
best
perform
inhospit
test
kit
mapic
fiv
test
sinovu
biotech
inc
lund
sweden
use
larg
number
invalid
result
result
difficult
interpret
unfortun
vaccin
cat
fiv
produc
antibodi
indistinguish
use
diagnos
fiv
infect
current
method
differenti
vaccin
antibodi
produc
natur
infect
therefor
attain
definit
diagnosi
cat
whose
vaccin
statu
unknown
becom
nearli
imposs
symptomat
therapi
use
control
uveiti
gondii
wellrecogn
caus
retin
choroid
anterior
uveiti
tachyzoit
target
eye
multipli
intracellularli
within
ocular
tissu
classic
funduscop
appear
multifoc
dark
gray
lesion
tapet
fundu
fluffi
white
infiltr
nontapet
fundu
gondii
frequent
implic
main
caus
acut
chronic
idiopath
felin
anterior
uveiti
support
evid
hypothesi
includ
higher
seropreval
rate
gondii
cat
uveiti
definit
diagnosi
histolog
identif
organ
histolog
diagnosi
frequent
avail
howev
serolog
test
primari
diagnost
modal
exposur
organ
widespread
within
felin
popul
therefor
pair
serolog
titer
recommend
case
remain
suspect
rather
confirm
elisa
test
igm
antibodi
singl
titer
greater
rise
igg
titer
consid
consist
activ
infect
recent
pcr
gene
test
gondiispecif
igm
igg
evalu
serum
aqueou
humor
sampl
gondiispecif
igm
igg
detect
serum
aqueou
humor
healthi
cat
cat
uveiti
gondiispecif
igm
igg
detect
serum
aqueou
humor
suggest
combin
serum
aqueou
humor
gondii
titer
may
inform
use
method
test
antiinflammatori
therapi
use
control
uveiti
conjunct
clindamycin
hydrochlorid
dose
mgkg
administ
oral
twice
daili
day
granulomat
anterior
uveiti
often
concurr
chorioretin
may
associ
cryptococcosi
histoplasmosi
blastomycosi
coccidioidomycosi
literatur
incid
blastomycosi
cat
seem
rare
except
sporad
cluster
case
hematogen
spread
like
rout
ocular
involv
ocular
cryptococcosi
seem
except
howev
extens
central
nervou
system
occur
frequent
diagnost
protocol
mycot
uveitid
includ
complet
physic
examin
hematolog
clinic
chemistri
diagnosi
often
achiev
identif
organ
cytolog
examin
aspir
impress
smear
lymph
node
bone
marrow
aspir
cerebrospin
fluid
cutan
lesion
aqueou
vitreou
paracentesi
may
use
depend
degre
ocular
involv
ie
anterior
posterior
segment
histoplasmosi
may
effect
treat
use
itraconazol
blastomycosi
may
treat
itraconazol
fluconazol
although
respons
often
poor
excel
review
articl
diseas
publish
wank
endophthalm
chorioretin
hyphema
report
associ
brucella
cani
infect
vinayak
colleagu
report
patient
b
cani
infect
demonstr
ocular
sign
clinic
sign
includ
reproduct
tract
lesion
eg
abort
epididym
failur
conceiv
diskospondyl
osteomyel
splenomegali
glomerulopathi
meningoenceph
isol
organ
consid
gold
standard
diagnost
test
difficult
howev
rapid
slide
agglutin
test
sensit
perform
earli
stage
infect
posit
result
confirm
test
includ
tube
agglutin
test
agargel
immunodiffus
indirect
fluoresc
antibodi
test
elisa
achiev
complet
erad
organ
difficult
variou
suggest
therapeut
regimen
includ
minocyclin
streptomycin
tetracyclin
streptomycin
longact
oxytetracyclin
enrofloxacin
gentamicin
complet
resolut
ocular
clinic
sign
clearanc
organ
report
one
case
literatur
borrelia
burgdorferi
lyme
diseas
ehrlichia
spp
includ
cani
plati
risticii
rickettsia
rickettsii
rocki
mountain
spot
fever
rmsf
implic
caus
agent
case
uveiti
ocular
lesion
similar
includ
anterior
uveiti
hyphema
retin
hemorrhag
retin
detach
see
fig
diagnosi
typic
base
combin
clinic
sign
serolog
test
serum
elisa
ifa
serolog
test
use
document
exposur
lyme
diseas
patient
previous
vaccin
lyme
diseas
western
blot
immunoassay
may
use
differenti
natur
exposur
vaccin
respons
serum
fluoresc
antibodi
test
reliabl
diagnosi
ehrlichi
agent
ifa
elisa
serum
antibodi
titer
avail
diagnosi
rmsf
current
therapeut
recommend
also
similar
doxycyclin
administ
dosag
mgkg
everi
hour
month
primari
therapi
lyme
diseas
patient
posit
serolog
clinic
sign
diseas
two
case
report
document
favor
respons
administr
doxycyclin
sometim
pair
antiinflammatori
dose
corticosteroid
case
canin
ehrlichiosi
doxycyclin
also
use
therapi
rmsf
combin
system
prednisolon
shown
decreas
efficaci
uveiti
rel
infrequ
present
reemerg
diseas
report
case
anterior
uveiti
one
case
bilater
serou
retin
detach
diagnosi
commonli
achiev
use
serum
microscop
agglutin
test
singl
high
titer
rise
titer
consid
indic
infect
therapi
direct
toward
elimin
organ
high
dose
penicillin
ampicillin
amoxicillin
clear
leptospiremia
phase
usual
within
hour
administr
drug
elimin
carrier
state
howev
current
recommend
use
cours
doxycyclin
clear
carrier
state
dog
blastomycosi
cryptococcosi
coccidiomycosi
histoplasmosi
system
mycos
commonli
involv
uveiti
patient
may
present
anterior
uveiti
chorioretin
panuv
endophthalm
optic
neuriti
complet
physic
examin
particular
attent
cutan
examin
thorac
auscult
abdomin
palpat
aid
establish
diagnosi
discuss
previous
cytolog
identif
organ
within
aspir
impress
smear
gold
standard
establish
diagnosi
serolog
test
avail
latex
cryptococc
agglutin
test
detect
cryptococc
antigen
use
test
establish
diagnosi
monitor
respons
therapi
serolog
test
histoplasmosi
blastomycosi
cocciciomycosi
detect
antibodi
product
falseneg
respons
least
blastomycosi
uncommon
prefer
system
therapi
type
mycosi
vari
current
prefer
therapi
blastomycosi
administr
itraconazol
although
mani
clinician
advoc
system
corticosteroid
treatment
dog
system
mycos
recent
retrospect
studi
dog
infect
blastomycosi
finn
colleagu
note
chang
surviv
time
suggest
combin
therapi
system
prednison
itraconazol
may
assist
mainten
vision
clinic
sign
uveiti
occur
result
inflamm
within
vascular
coat
eye
caus
breakdown
bab
bloodretin
barrier
clinic
sign
includ
blepharospasm
photophobia
conjunctiv
hyperemia
circumlimb
corneal
vascular
corneal
edema
aqueou
flare
inflammatori
cell
within
anterior
chamber
kerat
precipit
irid
congest
ocular
hypotoni
retin
hemorrhag
retin
detach
sequela
uveiti
includ
cataract
posterior
synechia
secondari
glaucoma
retin
degener
mani
infecti
noninfecti
caus
incit
episod
uveiti
therefor
complet
ocular
physic
examin
recommend
patient
uveiti
complet
blood
cell
count
serum
biochemistri
profil
urinalysi
thorac
radiograph
select
serolog
test
may
perform
effort
identifi
underli
etiolog
agent
despit
exhaust
workup
howev
underli
caus
determin
mani
case
goal
therapi
preserv
vision
possibl
minim
pain
halt
inflamm
addit
therapeut
agent
may
use
underli
etiolog
agent
identifi
